drugset / Trial / NCT00002720

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

NCT00002720

Phase 3 Completed 642 enrolled European Institute of Oncology
RandomizedTreatment

Summary

RATIONALE: Surgery to remove axillary lymph nodes may be an effective treatment for women with breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of therapy with or without axillary lymph node dissection following quadrantectomy in treating older women with stage I breast cancer that is estrogen receptor positive.

Timeline

Start
1995-12
Primary completion
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Background Tamoxifen Small molecule

Indications